Arshad A. Khan

Arshad A. Khan

Auto-generated profile, based on publicly available information

Arshad A. Khan

John Hunter Hospital Newcastle, NSW, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2017 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
AKArshad A. Khan
Arshad A. Khan
AAAsma Ashraf
Asma Ashraf
RSRajinder Singh
Rajinder Singh
ARAadil Rahim
Aadil Rahim
WRWalid Rostom
Walid Rostom
NCNicholas J. Collins
Nicholas J. Collins

14 December 2017 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
SBStephen C. Brienesse
Stephen C. Brienesse
ADAllan J. Davies
Allan J. Davies
AKArshad Khan
Arshad Khan
ABAndrew Boyle
Andrew Boyle

1 May 2017 in Medical Journal of Australia
Verified
Journal Article
Closed access
AKArshad A Khan
Arshad A Khan
PFPeter J Fletcher
Peter J Fletcher
ABAndrew Boyle
Andrew Boyle

5 July 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
AKArshad A Khan
Arshad A Khan
TWTrent Williams
Trent Williams
MRMax Ray
Max Ray
MAMohammed S Al-Omary
Mohammed S Al-Omary
JTJonah Taylor
Jonah Taylor
ABAndrew J Boyle
Andrew J Boyle
Objectives Elevated left ventricular end-diastolic pressure (LVEDP) in ST-segment elevation myocardial infarction (STEMI) has been studied in patients who received thrombolysis or who were treated early in the primary percutaneous coronary intervention (PCI) era; LVEDP was found to be a predictor of adverse outcomes in these retrospective post hoc analyses. The aim of the current analysis is to assess the prognostic value of the elevated LVEDP in STEMI patients undergoing primary PCI in current contemporary practice. Design Prospective, single-centre study. Participants Our study enrolled STEMI patients with elevated LVEDP undergoing primary PCI at John Hunter Hospital, Newcastle, Australia. Primary outcome measure The primary endpoint was the combination of 12-month all-cause mortality and heart failure admissions, comparing different quartiles of LVEDP. Results A total of 997 patients underwent primary PCI at our hospital during the 5-year study period (age: 64±13 years, males: 73%; n=728) from 1 January 2015 to 31 December 2019. The median LVEDP for the whole cohort was 27 mm Hg (IQR: 22–31 mm Hg). The median LVEDP was 17 mm Hg (IQR: 13–18 mm Hg) and 33 mm Hg (IQR: 30–36 mm Hg) for 1st and 4th quartiles respectively (p<0.01). At 1 year, the composite endpoint of all-cause mortality or heart failure admission was 12% vs 26% (p=0.01) in quartiles 1 and 4 respectively. The mean left ventricular ejection fraction (LVEF) for the whole cohort was 50%. In multivariate regression analysis, age, anterior STEMI, out of hospital cardiac arrest and LVEDP quartile 4 were independent predictors of mortality; LVEF was not. Conclusions LVEDP is an independent predictor of adverse outcomes in STEMI patients, despite a relatively normal LVEF. Further prospective studies are needed to assess the effects of early reduction in LVEDP on the prognosis.

3 July 2026 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
TQThomas Quirk
Thomas Quirk
SSShanathan Sritharan
Shanathan Sritharan
KSKaylea Short
Kaylea Short
LMLewis McLean
Lewis McLean
AKArshad Khan
Arshad Khan
MAMohammad Al-Omary
Mohammad Al-Omary